Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Cancer Chemotherapy and Pharmacology|September 5, 2003
Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cellsDavid Y Bouffard, Jacques Jolivet, Lorraine Leblond, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Species differences in troxacitabine pharmacokinetics and pharmacodynamics: implications for clinical developmentHenriette Gourdeau, Lorraine Leblond, Bettina Hamelin, et al.Clinical Colorectal Cancer|May 27, 2008
A four-arm, randomized, multicenter phase II trial of oxaliplatin combined with varying schedules of 5-fluorouracil as first-line therapy in previously untreated advanced colorectal cancerRamesh K Ramanathan, Georg A Bjarnason, Stephen Alan Bernard, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2002
Phase I and pharmacokinetic study of novel L-nucleoside analog troxacitabine given as a 30-minute infusion every 21 daysKarl Bélanger, Malcolm Moore, Sharyn D Baker, et al.American Journal of Clinical Oncology|March 24, 2012
Phase I trial of AEG35156 an antisense oligonucleotide to XIAP plus gemcitabine in patients with metastatic pancreatic ductal adenocarcinomaDaruka Mahadevan, Pavani Chalasani, Diane Rensvold, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Population pharmacokinetics of troxacitabine, a novel dioxolane nucleoside analogueCarlton K K Lee, Eric K Rowinsky, Jing Li, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Troxacitabine, an L-stereoisomeric nucleoside analog, on a five-times-daily schedule: a phase I and pharmacokinetic study in patients with advanced solid malignanciesJohann S de Bono, Joseph Stephenson, Sharyn D Baker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with refractory leukemiaFrancis J Giles, Guillermo Garcia-Manero, Jorge E Cortes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2009
Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancerEmma Dean, Duncan Jodrell, Kate Connolly, et al.Pageof 2